Economic Profitability of the Biopharmaceutical Industry 2022 - Intensity Website
5
(668) ·
$ 2.50 ·
In stock
Description
Pharma Industry & CDMO Outlook: 2022 & Near Term - DCAT Value Chain Insights
How the Inflation Reduction Act Will Impact the Biopharmaceutical Industry
Margin pressure requires shift from 'grow at all costs' to profitability
Mexican manufacturing: so far from EU, so close to US - Pharmaceutical Technology
3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2%
Industry Primer: Biotech
ESG & Long-Term Disclosures: The State of Play in Biopharma
With Market Size Valued at $19.6 Billion by 2026, it`s a Healthy Outlook for the Global Biopharmaceutical Bioseparation Systems Market
Drug Discovery Services Market Revenue Forecast, Latest Industry Updates
Biologics Market Economic Growth CAGR of 9.1%, Restraints, Mergers And Forecast (2022-2032)
Margin pressure requires shift from 'grow at all costs' to profitability
The Economics of Biopharmaceutical Innovation: Symposium Report
The Economics of Biopharmaceutical Innovation: Symposium Report
For Biopharma, a Rising Tide—and Choppy Waters
IBI Spring 2022 by Senglobal1 - Issuu
Related products
You may also like
copyright © 2019-2024 osihenoutlet.com all rights reserved.